The Clinical Champions programme has opened all kinds of doors and turbo-boosted everything!
What is the Clinical Champions programme?
Our 18 month long programme aims to identify future clinical leaders and provide them with the knowledge, skills and support to deliver significant improvements to prostate cancer care.
What does the programme involve?
We have partnered with the innovative Living Potential to bring you a bespoke clinical leadership programme that will support you to drive meaningful improvements for those living with or at risk of prostate cancer.
Through the programme you will receive:
- Training on change leadership, system leadership, improvement science and implementing an improvement project.
- Virtual improvement group meetings that allow time to connect with peers
- Individual support around your improvement ambitions and leadership development.
- Opportunities to meet and network with inspiring leaders
- Networking, sharing insights and learning from fellow peers on the programme.
- Support from Prostate Cancer UK during and beyond the programme.
Who is the programme for?
We know all roles across the prostate cancer pathway are critical to transforming care. That’s why we take a multi-disciplinary approach to this programme. The programme is open to passionate and experienced practicing clinicians from a variety of professional backgrounds who are driven to improve prostate cancer care.
We would like to encourage applications from nurses, primary care and clinicians in Northern Ireland, Scotland and Wales.
How can I apply?
We are currently closed for applications. To register your interest in this programme, please use the button below to register your details with us and we will be in contact when we are opening for a new cohort.
If you have any questions about our programmes please get in touch [email protected].
This programme has helped me change my approach- I’m now able to work in a systematic way to bring about a resolution.
The Prostate Cancer Improvement Programmes are partly supported by grants from Astellas Pharma Ltd, Bayer UK and Roche Products Ltd. None of these organisations have had any control over the educational content of this activity.